IL1B and cancer: Recently, Zhao et al. reviewed the double-edged sword effect of inflammation in cancer progression, i.e., the cancer-inhibiting acute inflammation and cancer-promoting chronic inflammation, and found that inflammasomes mediate pyroptosis, release IL-1β and IL-18, and activate a strong inflammatory response [22].